HPV legislation in Hawaii

Women in Government Ratings
Women in Government, a non-profit network of state level women legislators, receives significant funding from the pharmaceutical industry, including Merck, GlaxoSmithKline, and Digene Corporation -- all with products related to HPV vaccination and testing. According to their report, "The 'State' of Cervical Cancer Prevention in America - 2008" :

POPULATION: 1,285,498

Incidence & Mortality (2008 Score / 2007 Score)
 * Cervical Cancer Incidence Rate: 6.3/100,000 (2 / 1)
 * Cervical Cancer Incidence Rate/Race: White: 7.9, Asian/Pacific Islander: 6.3
 * Cervical Cancer Mortality Rate: 2.4/100,000 (1 / 1)
 * Cervical Cancer Mortality Rate/Race: White: 2.1, Asian/Pacific Islander: 2.5

Screening (2008 Score / 2007 Score)
 * Cervical Cancer Screening Rate: 82.0% (1 / 1)
 * Cervical Cancer Screening Rate/Race: White: 86.2, Hispanic: 83.2%%, Asian/Pacific Islander: 78.2%
 * % Uninsured/Unscreened: 29.1% (1 / 1)
 * Medicaid Coverage HPV Testing: Unrestricted (2 / 2)

Healthcare Access (2008 Score / 2007 Score)
 * Rate Uninsured Women: 11% (1 / 1)
 * % Low Income/Uninsured Women: 22%

Policy Initiatives and Infrastructure (2008 Score / Cumulative Score (2005–2008)

Screening Requirements (0 / 1)
 * There are no new screening requirements.

Task Forces (0 / 1)
 * There is no new cervical cancer prevention task force legislation.

Access to HPV Vaccines (1 / 1)
 * HB 1000 would include the HPV vaccine in the Teen Vax Program for uninsured/underinsured girls age 11–18; carried over to 2008 session.
 * HB 590 requires health insurance policies issued in the state to cover the HPV vaccine for people age 11–26; directs Dept. of Health to include HPV vaccine in Teen Vax Program; carried over to 2008 session.

HPV Vaccine Information Programs (0 / 0)
 * There is no HPV vaccine information activity.

Miscellaneous (1 / 2)
 * SR 137/SCR 213 and HR 160/HCR 202 request the governor to fund breast and cervical cancer screening for low-income women; passed.
 * HB 459/SB 1108 would appropriate funding to the Dept. of Health and women’s caucus to conduct an educational program about the causesand prevention of cervical cancer; carried over to 2008 session.

Annual Ratings
 * 2008: Good (13 out of 22 points)
 * 2007: Good (11 out of 18 points)

SourceWatch Resources

 * Gardasil
 * GlaxoSmithKline
 * Merck
 * Women in Government
 * Edelman
 * The Marketing of Gardasil in Australia
 * The Marketing of Gardasil in Canada
 * The Marketing of Gardasil in Europe
 * The Marketing of Gardasil in New Zealand
 * The Marketing of Gardasil in the United States
 * Direct-to-consumer advertising
 * Disease Mongering
 * Drug industry